342
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Survivorship

Who are the vulnerable lung cancer patients at risk for not receiving first-line curative or palliative treatment?

ORCID Icon, , , , , , , , ORCID Icon & show all
Pages 1301-1308 | Received 01 May 2023, Accepted 21 Aug 2023, Published online: 01 Sep 2023

References

  • Dalton SO, Steding-Jessen M, Jakobsen E, et al. Socioeconomic position and survival after lung cancer: influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010. Acta Oncol. 2015;54(5):797–804. doi:10.3109/0284186X.2014.1001037.
  • Kærgaard Starr L, Osler M, Steding-Jessen M, et al. Socioeconomic position and surgery for early-stage non-small-cell lung cancer: a population-based study in Denmark. Lung Cancer. 2013;79(3):262–269. doi:10.1016/j.lungcan.2012.11.023.
  • Berglund A, Lambe M, Luchtenborg M, et al. Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open. 2012;2(3):e001048. doi:10.1136/bmjopen-2012-001048.
  • Elliott I, Gonzalez C, Backhus L, et al. Social disparities in lung cancer. Thorac Surg Clin. 2022;32(1):33–42. doi:10.1016/j.thorsurg.2021.09.009.
  • Tendler S, Holmqvist M, Wagenius G, et al. Educational level, management and outcomes in small-cell lung cancer (SCLC): a population-based cohort study. Lung Cancer. 2020;139:111–117. doi:10.1016/j.lungcan.2019.11.008.
  • Willen L, Berglund A, Bergstrom S, et al. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study. Lung Cancer. 2019;131:40–46. doi:10.1016/j.lungcan.2019.03.004.
  • Forrest LF, Adams J, Wareham H, et al. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLOS Med. 2013;10(2):e1001376. doi:10.1371/journal.pmed.1001376.
  • Halgren MO, Kjær TK, Dalton SO. Hvidbog - Social ulighed i kræft i Danmark. 2019.
  • Diderichsen F, Andersen I, Manuel C, et al. Health inequality–determinants and policies. Scand J Public Health. 2012;40(8 Suppl):12–105. doi:10.1177/1403494812457734.
  • Gironés R, Torregrosa D, Gómez-Codina J, et al. Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians. Clin Transl Oncol. 2012;14(3):183–189. doi:10.1007/s12094-012-0782-6.
  • Salloum RG, Smith TJ, Jensen GA, et al. Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer. Lung Cancer. 2012;75(2):255–260. doi:10.1016/j.lungcan.2011.07.005.
  • Blom EF, Ten Haaf K, Arenberg DA, et al. Disparities in receiving guideline-concordant treatment for lung cancer in the United States. Ann Am Thorac Soc. 2020;17(2):186–194. doi:10.1513/AnnalsATS.201901-094OC.
  • Wang S, Wong ML, Hamilton N, et al. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol. 2012;30(13):1447–1455. doi:10.1200/JCO.2011.39.5269.
  • Grønberg BH, Sundstrøm S, Kaasa S, et al. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010;46(12):2225–2234. doi:10.1016/j.ejca.2010.04.009.
  • Søgaard M, Thomsen RW, Bossen KS, et al. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5(Suppl 1):3–29. doi:10.2147/CLEP.S47150.
  • Bergamo C, Sigel K, Mhango G, et al. Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study. Psychosom Med. 2014;76(3):215–220. doi:10.1097/PSY.0000000000000050.
  • Greer JA, Pirl WF, Park ER, et al. Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res. 2008;65(6):549–552. doi:10.1016/j.jpsychores.2008.03.005.
  • Christensen NL, Dalton S, Ravn J, et al. Treatment, no treatment and early death in Danish stage I lung cancer patients. Lung Cancer. 2019;131:1–5. doi:10.1016/j.lungcan.2019.03.007.
  • Tataru D, Spencer K, Bates A, et al. Variation in geographical treatment intensity affects survival of non-small cell lung cancer patients in England. Cancer Epidemiol. 2018;57:13–23. doi:10.1016/j.canep.2018.09.001.
  • Crawford SM, Sauerzapf V, Haynes R, et al. Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer. 2009;101(6):897–901. doi:10.1038/sj.bjc.6605257.
  • Jones AP, Haynes R, Sauerzapf V, et al. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer. 2008;44(7):992–999. doi:10.1016/j.ejca.2008.02.001.
  • Tracey E, McCaughan B, Badgery-Parker T, et al. Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study. Thorax. 2015;70(2):152–160. doi:10.1136/thoraxjnl-2014-205554.
  • Jakobsen E, Rasmussen TR. The Danish lung cancer registry. Clin Epidemiol. 2016;8:537–541. doi:10.2147/CLEP.S99458.
  • Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125.
  • Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. doi:10.1093/aje/kwq433.
  • Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011; 39(7 Suppl):91–94. doi:10.1177/1403494810394715.
  • Potosky AL, Saxman S, Wallace RB, et al. Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol. 2004;22(16):3261–3268. doi:10.1200/JCO.2004.02.051.
  • Lüchtenborg M, Jakobsen E, Krasnik M, et al. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer. 2012;48(18):3386–3395. doi:10.1016/j.ejca.2012.06.012.
  • Kaplan AL, Crespi CM, Saucedo JD, et al. Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial. Cancer. 2014;120(17):2721–2727. doi:10.1002/cncr.28755.
  • Koay K, Schofield P, Jefford M. Importance of health literacy in oncology. Asia Pac J Clin Oncol. 2012;8(1):14–23. doi:10.1111/j.1743-7563.2012.01522.x.
  • Siminoff LA, Graham GC, Gordon NH. Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors. Patient Educ Couns. 2006; 62(3):355–360. doi:10.1016/j.pec.2006.06.011.
  • Smith SK, Dixon A, Trevena L, et al. Exploring patient involvement in healthcare decision making across different education and functional health literacy groups. Soc Sci Med. 2009;69(12):1805–1812. doi:10.1016/j.socscimed.2009.09.056.
  • Dencker A, Tjørnhøj-Thomsen T, Pedersen PV. A qualitative study of mechanisms influencing social inequality in cancer communication. Psychooncology. 2021;30(11):1965–1972. doi:10.1002/pon.5767.
  • Aizer AA, Chen MH, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31(31):3869–3876. doi:10.1200/JCO.2013.49.6489.
  • Chen Z, Yin K, Zheng D, et al. Marital status independently predicts non-small cell lung cancer survival: a propensity-adjusted SEER database analysis. J Cancer Res Clin Oncol. 2020;146(1):67–74. doi:10.1007/s00432-019-03084-x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.